ACXP

Acurx Pharmaceuticals, Inc. ACXP

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $0.0M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Top Institutional Holders

as of Q2 2026
$192.8K total
VANGUARD CAPITAL MANAGEMENT LLC
$48.2K0.0%
GEODE CAPITAL MANAGEMENT, LLC
$40.9K+6.4%
VANGUARD FIDUCIARY TRUST CO
$25.1K0.0%
JANE STREET GROUP, LLC
$24.4K-71.2%
Prospect Financial Services LLC
$21.4K0.0%
MORGAN STANLEY
$11.6K+15.4%
Integrated Wealth Concepts LLC
$7.3KNew
Tower Research Capital LLC (TRC)
$4.3K+166.1%
WELLS FARGO & COMPANY/MN
$3.6K0.0%
Westside Investment Management, Inc.
$2.6K0.0%
NBC SECURITIES, INC.
$2.3K0.0%
BARCLAYS PLC
$436-26.1%
Cornerstone Planning Group LLC
$2450.0%
OSAIC HOLDINGS, INC.
$1550.0%
GROUP ONE TRADING, L.P.
$147-61.2%
BlackRock, Inc.
$930.0%
Caitong International Asset Management Co., Ltd
$36New
SBI Securities Co., Ltd.
$90.0%
UBS Group AG
$5-100.0%
NewEdge Advisors, LLC
$0New
See all 20 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/ACXP

Earnings Per Share

13fpro.ai/company/ACXP

Loading ratio trend…

About Acurx Pharmaceuticals, Inc. (ACXP): stock profile, AI score and financials

Acurx Pharmaceuticals, Inc. (ACXP) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. ACXP is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Top institutional holders of ACXP by reported 13-F value include VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, VANGUARD FIDUCIARY, based on the most recent SEC filings. ACXP trades on the Nasdaq exchange and files with the SEC under CIK 1736243. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ACXP daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Acurx Pharmaceuticals, Inc. directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1736243 →